Scilex Holding Co. (SCLX)
5.495
+0.06
(+1.20%)
USD |
NASDAQ |
Aug 31, 16:00
5.59
+0.10
(+1.73%)
After-Hours: 07:22
Scilex Shareholders Equity (Quarterly) : -308.32M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -308.32M |
| March 31, 2026 | -249.22M |
| December 31, 2025 | -207.78M |
| September 30, 2025 | -176.94M |
| June 30, 2025 | -248.99M |
| March 31, 2025 | -211.48M |
| December 31, 2024 | -192.64M |
| September 30, 2024 | -211.32M |
| June 30, 2024 | -214.69M |
| March 31, 2024 | -189.79M |
| December 31, 2023 | -172.94M |
| September 30, 2023 | -162.67M |
| Date | Value |
|---|---|
| June 30, 2023 | 10.42M |
| March 31, 2023 | 11.08M |
| December 31, 2022 | 36.24M |
| September 30, 2022 | 89.29M |
| June 30, 2022 | 89.42M |
| March 31, 2022 | 129.88M |
| December 31, 2021 | -223.88M |
| September 30, 2021 | 129.55M |
| June 30, 2021 | 130.99M |
| March 31, 2021 | 131.23M |
| December 31, 2020 | 0.0187M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 317.47M |
| Semnur Pharmaceuticals, Inc. | -29.67M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.56M |
| Total Liabilities (Quarterly) | 564.05M |
| Debt to Equity Ratio | -0.3437 |
| Current Ratio | 0.0707 |
| Net Debt Paydown Yield | -20.84% |